Singapore Markets closed

My 3 Favorite Under-the-Radar Healthcare Stocks for 2022

·5-min read
My 3 Favorite Under-the-Radar Healthcare Stocks for 2022
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Looking for investment opportunities in the healthcare sector, and particularly in the biotechnology industry, can be overwhelming if you're not intimately familiar with the space. Here are three companies that operate surprisingly diverse operations -- either through drug pipeline variety, customer diversification, or differentiated product verticals -- offering a safety net, as well as prospects for growth, to their shareholders as a result. Led by its mission "to help people access, understand, and benefit from the human genome," 23andMe Holding (NASDAQ: ME) has quietly identified over 40 therapeutic programs from its treasure trove of genetic data.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting